Androgen Receptor Expression in ER and PR Negative Breast Cancer—A Study from a Tertiary Hospital in Northern India

Androgen Receptor Expression in ER and PR Negative Breast Cancer—A Study from a Tertiary Hospital in Northern India

Bibliographic Details
Main Authors:	Sumeet Sidhu, Kanwardeep Singh Kwatra, Pamela Alice Kinsley
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2023-10-01
Series:	South Asian Journal of Cancer
Subjects:	androgen breast carcinoma estrogen Her2 TNBC
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1768920

Similar Items

Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)

An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers
by: Savitha Rajarajan, et al.
Published: (2023-11-01)

Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
by: Xia Qiu, et al.
Published: (2022-02-01)

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
by: Sindhu Govindan, et al.
Published: (2020-08-01)

Prevalence of Androgen Receptor in Invasive Breast Cancer and Its Association with Clinicopathologic Features in East Azarbaijan Province of Iran: A Cross-Sectional Study
by: Alireza Nikanfar, et al.
Published: (2023-07-01)

Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer
by: Monika Pizon, et al.
Published: (2018-12-01)

Correlation between the number of breast duct cells expressing androgen, estrogen and progesterone receptors and the size of the changed tissue in patients with gynecomastia
by: Mladenović Danilo, et al.
Published: (2023-01-01)

Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab
by: Jie Li, et al.
Published: (2020-09-01)

Prognostic significance of ER-to-PR difference in ER+/HER2- early breast cancer
by: Xiaoyan Wu, et al.
Published: (2024-10-01)

Expression of ER and AR in lung cancer
by: Shuling WANG, et al.
Published: (2008-02-01)

In silico and in vitro evaluation of potential agonistic and antagonistic estrogenic and androgenic activities of pure cyanotoxins, microcystin-LR and cylindrospermopsin
by: Antonio Casas-Rodríguez, et al.
Published: (2025-01-01)

ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities
by: Alessandra Monaco, et al.
Published: (2021-09-01)

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
by: Aristomenis Anestis, et al.
Published: (2020-01-01)

COMPARISON OF ANDROGEN AND ESTROGEN RECEPTORS’ EXPRESSION IN DARTOS TISSUE OF BOYS WITH AND WITHOUT HYPOSPADIAS
by: Aria Danurdoro, et al.
Published: (2023-01-01)

Antiproliferative effect of Saraca asoca methanol bark extract on triple negative breast cancer (TNBC)
by: Chennattu M. Pareeth, et al.
Published: (2024-03-01)

Androgen receptor expression and clinical characteristics in breast cancer
by: Dan-dan Wang, et al.
Published: (2024-09-01)

ER/AR Multi-Conformational Docking Server: A Tool for Discovering and Studying Estrogen and Androgen Receptor Modulators
by: Feng Wang, et al.
Published: (2022-01-01)

Expression of androgen, estrogen, and progesterone hormone receptors in the penile tissues of children with different types of hypospadias
by: Ayşenur Celayir, et al.
Published: (2019-06-01)

Effects of Oral Contraceptive Androgenicity on Visuospatial and Social-Emotional Cognition: A Prospective Observational Trial
by: Caroline Gurvich, et al.
Published: (2020-03-01)

HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel
by: Hui Lyu, et al.
Published: (2023-09-01)

Measurement of Androgen and Estrogen Concentrations in Cord Blood: Accuracy, Biological Interpretation and Applications to Understanding Human Behavioural Development
by: Lauren P Hollier, et al.
Published: (2014-05-01)

Expression of Androgen, Estrogen, and Progesterone Receptors in the Skin of Patients with Severe Acne and the Assessment of Their Predictive Potential Using Artificial Intelligence Methods
by: Olga M. Demina
Published: (2024-12-01)

Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat[S]
by: Hua Zhang, et al.
Published: (2013-02-01)

Androgen receptor in relation to progesterone receptor (AR/PR ratio) in non-metastatic hormonal positive, Her2neu negative breast cancer
by: Maged A.F. Amine, et al.
Published: (2024-01-01)

Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer
by: Amal Qattan, et al.
Published: (2022-02-01)

Prognostic Value of Androgen Receptor in Triple Negative Breast Cancer of Iranian Patients in Yazd Region
by: Fatemeh Alsadat Nobakht, et al.
Published: (2020-11-01)

Organizational Effects of Estrogens and Androgens on Estrogen and Androgen Receptor Expression in Pituitary and Adrenal Glands in Adult Male and Female Rats
by: Natalia Lagunas, et al.
Published: (2022-06-01)

Steroidogenesis and androgen/estrogen signaling pathways are altered in in vitro matured testicular tissues of prepubertal mice
by: Laura Moutard, et al.
Published: (2023-12-01)

Direct and indirect effects of estrogens, androgens and intestinal microbiota on colorectal cancer
by: Zihong Wu, et al.
Published: (2024-11-01)

Immunohistochemical study of androgen, estrogen and progesterone receptors in salivary gland tumors
by: Fabio Augusto Ito, et al.
Published: (2009-12-01)

Predictive Models for Compound Binding to Androgen and Estrogen Receptors Based on Counter-Propagation Artificial Neural Networks
by: Mark Stanojević, et al.
Published: (2023-05-01)

Immunohistochemistry Study on Androgen and Estrogen Receptors of Rat Seminal Vesicle Submitted to Simultaneous Alcohol-Nicotine Treatment
by: Mohsen Basiri, et al.
Published: (2016-09-01)

miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1
by: Yan Li, et al.
Published: (2020-08-01)

<i>f</i>HER2, PR, ER, Ki-67 and Cytokeratin 5/6 Expression in Benign Feline Mammary Lesions
by: Maria Soares, et al.
Published: (2022-06-01)

Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients treated with neoadjuvant therapy
by: Haizhu Chen, et al.
Published: (2024-06-01)

Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone
by: Jason A. Mouabbi, et al.
Published: (2021-07-01)

Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia
by: Lingmin Song, et al.
Published: (2016-07-01)

Comparison of FGF-8, FGF-10, FGF-Receptor 2, Androgen Receptor, Estrogen Receptor-A and SS in Healthy and Hypospadiac Children
by: Emaratpardaz N, et al.
Published: (2024-09-01)

Androgen Receptor is a Negative Regulator of PRDM16 in Beige Adipocyte
by: Shiting Zhao, et al.
Published: (2023-07-01)

The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer
by: Yan Shen, et al.
Published: (2017-10-01)